Thursday, 30 July 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 30 July 2026
News

Lilly, Roche sign Alzheimer's plan

Posted 30 July 2026 PM

Eli Lilly Australia today signed a three-way collaboration with Roche Diagnostics and not-for-profit medical research institution Neuroscience Research Australia (NeuRA) to tackle the looming dementia crisis in Australia, and gather data for HTA processes along the way. 

A memorandum of understanding between the three organisations aims to put into practice the National Dementia Action Plan which was released in 2024, piloting a new care model in NSW that integrates blood-based biomarkers (BBMs), imaging, and treatments into streamlined referral pathways, using standard, clinically registered diagnostics and therapies.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (19)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.